Immunogenomics market outlook 2026–2030 driven by key growth factors and projections

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Immunogenomics Market During 2026–2030?

The immunogenomics market has seen rapid expansion in recent years. It is anticipated to grow from $6.09 billion in 2025 to $7.07 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. This historical growth can be attributed to developments in genomic sequencing technologies, an improved understanding of immune-related genetic variations, the expansion of oncology and infectious disease research, increased funding for research, and the availability of high-throughput genomic tools.

The immunogenomics market is projected to experience substantial expansion in the coming years, reaching a valuation of $12.73 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.8%. This anticipated growth stems from several factors, including the escalating need for precision medicine solutions, the ongoing development of tailored vaccines and immunotherapies, the broadening scope of translational immunogenomics research, increased integration of multi-omics data, and the rising uptake of cloud-based genomic analytics. Key developments shaping this period encompass the growing incorporation of next-generation sequencing for immune profiling, the enhanced application of bioinformatics tools in immune data analysis, a heightened emphasis on individualized immunotherapies, the expansion of genomic databases dedicated to immune research, and the advanced integration of artificial intelligence into immunogenomic investigations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

What Factors Are Contributing To The Growth Of The Immunogenomics Market?

The expanding occurrence of infectious diseases is anticipated to drive the advancement of the immunogenomics market in the future. These diseases are defined as ailments resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals through direct or indirect contact. The escalating frequency of infectious diseases is attributable to greater travel, which aids in the swift dissemination of pathogens across different regions. Immunogenomics improves the management of infectious diseases by allowing for accurate examination of host immune reactions and genetic predispositions. This field minimizes empirical treatment approaches by pinpointing immune factors specific to each patient, thereby enhancing diagnostic methods, vaccine creation, and tailored therapeutic plans. For instance, in February 2024, data from the UK Health Security Agency, a UK-based government body, showed that cases of tuberculosis, a communicable bacterial infection primarily affecting the lungs, in England climbed to 4,850 in 2023, representing a 10.7% increase from 4,380 cases in 2022. Consequently, the expanding occurrence of infectious diseases is fueling the expansion of the immunogenomics market.

What Are The Different Segment Types In The Immunogenomics Market Segment Breakdown?

The immunogenomics market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Software, Services

2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies

3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Sequencers, Microarray scanners, Flow cytometers

2) By Consumables: Reagents, Kits, Assay panels

3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms

4) By Services: Sequencing services, Genomic profiling, Bioinformatics support

What Trends Are Shaping The Future Of The Immunogenomics Market?

Key companies in the immunogenomics market are concentrating on creating sophisticated solutions, such as vaccine target prediction systems. These systems enable automated, comprehensive vaccine design and optimize vaccine structures by ensuring ideal antigen sequencing. A vaccine target prediction system operates as a computational platform, leveraging bioinformatics algorithms alongside genomic and immunomic data to identify potential antigen molecules from pathogens or cancer cells. It then analyzes their structural characteristics to prioritize and choose the best vaccine candidates most likely to generate protective immune responses. For example, in September 2024, Evaxion Biotech A/S, a Denmark-based biotechnology company specializing in artificial intelligence-driven immunotherapy and vaccine development, introduced its clinically validated AI-Immunology platform. This upgraded EDEN artificial intelligence prediction model incorporates a new toxin antigen predictor, enhancing the accuracy and reliability of bacterial toxin antigen identification for next-generation bacterial vaccine development. Additionally, this platform simulates the immune system to devise personalized and advanced immunotherapies and has demonstrated strong correlations between its AI-generated predictions and clinical outcomes.

Who Are The Well-Known Companies In The Immunogenomics Market?

Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., BioAnalytica Biotechnology Systems Inc.

Get The Full Immunogenomics Market Report:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

Where Is The Immunogenomics Market Most Concentrated Geographically?

North America was the largest region in the immunogenomics market in 2025. The regions covered in the immunogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Immunogenomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

Browse Through More Reports Similar to the Global Immunogenomics Market 2026, By The Business Research Company

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795